Literature DB >> 19406052

[Desmoid tumor of the thoraco-abdominal wall characterized with 18F-fluorodeoxyglucose PET/ CT scan. Correlation with magnetic resonance and bone scintigraphy. Review of the literature].

C Ramos-Font1, A Santiago Chinchilla, A C Rebollo Aguirre, A Rodríguez Fernández, A Medina Benítez, J M Llamas Elvira.   

Abstract

Desmoid tumours are uncommon benign tumours but with aggressive behaviour, resulting from the proliferation of well-differentiated fibroblasts. Clinically, they present as a painless firm soft tissue mass. They can be solitary or multiple and have potential infiltrative capacity. When planning treatment, it is important to assess the correct tumour extent to permit curative radical surgery minimizing possible local recurrence. Different imaging techniques help to characterise these tumours. At present, magnetic resonance is the tool of choice for studying these tumours. The role of nuclear medicine techniques, such as bone scintigraphy, or more recently FDG-PET, has not been defined in the evaluation of these neoplasms. We present the case of a patient with a desmoid tumour of the abdominal-chest wall and we review the related literature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406052     DOI: 10.1016/s0212-6982(09)70700-1

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  4 in total

1.  Desmoid tumour (aggressive fibromatosis) of the colon mimics malignancy on dual time-point 18F-FDG PET/CT imaging.

Authors:  W Makis; A Ciarallo; G Abikhzer; J Stern; J Laufer
Journal:  Br J Radiol       Date:  2012-02       Impact factor: 3.039

2.  Diagnostic imaging and CEUS findings in a rare case of Desmoid-type fibromatosis. A case report.

Authors:  Massimo Valentino; Mauro Liberatore; Fabrizio Maghella; Valeria De Soccio; Carlo De Felice; Daniela Messineo; Francesco Maria Drudi
Journal:  J Ultrasound       Date:  2018-03-21

3.  Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib.

Authors:  Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Peter Hohenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-19       Impact factor: 9.236

4.  Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib.

Authors:  Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Lothar R Pilz; Ludwig G Strauss; Christos Sachpekidis; Peter Hohenberger
Journal:  Biomed Res Int       Date:  2013-05-16       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.